Clinical Trials Browser

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07321652 2026-01-07

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Phase 3 Not yet recruiting

466 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07286539 2025-12-16

PEPOH

Phase NA Not yet recruiting

150 enrolled

BreastGastrointestinalLymphoidOther hematologic neoplasmThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Lymphoma, Motor Activity, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT06792994 2025-12-02

CLL2000

Not yet recruiting

2,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07225439 2025-11-06

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Phase 1 Not yet recruiting

15 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07162532 2025-09-09

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

Not yet recruiting

45 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07157579 2025-09-05

Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient

Not yet recruiting

80 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07113132 2025-08-08

Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia

Not yet recruiting

84 enrolled

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07082452 2025-07-24

SEVENAZA

Phase 3 Not yet recruiting

262 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT06862323 2025-06-13

Time Restricted Eating in Haematological Malignancies

Phase 2 Not yet recruiting

75 enrolled

LymphoidOther hematologic neoplasm

Intermittent Fasting, Inflammation, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07003464 2025-06-04

Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study

Phase 2 Not yet recruiting

30 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06654206 2025-02-19

Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia Patients

Phase EARLY_PHASE1 Not yet recruiting

40 enrolled

LymphoidOther hematologic neoplasm

Motor Activity, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05371392 2024-06-20

Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia

Not yet recruiting

80 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06416267 2024-05-16

MBL RiskConseq

Not yet recruiting

1,500 enrolled

LymphoidOther hematologic neoplasm

Alzheimer Disease, Autoimmune Diseases, Cardiovascular Diseases, Dementia, Infections, Neoplasms, Parkinson Disease, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06364033 2024-05-09

Biological and Clinical Efficacy of Shingrix in Patients With CLL

Phase NA Not yet recruiting

312 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05718986 2024-05-08

Familial_LPD

Not yet recruiting

1,000 enrolled

LymphoidOther hematologic neoplasmOther neoplasm

Lymphoproliferative Disorders, Precancerous Conditions, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06367374 2024-04-16

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL

Phase 2 Not yet recruiting

66 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06084923 2024-04-10

Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression

Not yet recruiting

73 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05923502 2023-10-23

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

Not yet recruiting

200 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, B-Cell, Marginal Zone

NCT04790045 2023-10-03

LymBIO

Phase 4 Not yet recruiting

30 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Clinical Trials

STOP-CLL-DCT

Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

Archonc-001

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

ACITAC-001

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

PEPOH

CLL2000

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients

Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient

Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia

SEVENAZA

Time Restricted Eating in Haematological Malignancies

Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study

Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia Patients

Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia

MBL RiskConseq

Biological and Clinical Efficacy of Shingrix in Patients With CLL

Familial_LPD

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL

Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

LymBIO